Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.
- DOI
- 10.1136/bmjopen-2025-104517
- Published
- 2025 Dec 29
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-104517,
title = {Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.},
author = {Buscail E and Gilletta de Saint Joseph C and Lebrin M and Frument I and Gross F and Bournet B and Buscail L and Culetto A and Mokrane F and Delchier MC and Quelven I and Daguzan C and Pugnet G and Duffas JP and Ghouti L and Philis A and Carrere N and Lepage B and Le Cosquer G},
year = {2025},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-104517},
url = {https://doi.org/10.1136/bmjopen-2025-104517}
}RIS
TY - JOUR TI - Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula. AU - Buscail E AU - Gilletta de Saint Joseph C AU - Lebrin M AU - Frument I AU - Gross F AU - Bournet B AU - Buscail L AU - Culetto A AU - Mokrane F AU - Delchier MC AU - Quelven I AU - Daguzan C AU - Pugnet G AU - Duffas JP AU - Ghouti L AU - Philis A AU - Carrere N AU - Lepage B AU - Le Cosquer G PY - 2025 JO - BMJ open DO - 10.1136/bmjopen-2025-104517 UR - https://doi.org/10.1136/bmjopen-2025-104517 ER -
APA
E, B., C, G. D. S. J., M, L., I, F., F, G., B, B., L, B., A, C., F, M., MC, D., I, Q., C, D., G, P., JP, D., L, G., A, P., N, C., B, L., & G, L. C. (2025). Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.. BMJ open. https://doi.org/10.1136/bmjopen-2025-104517
Source records
- pubmed · retrieved 2026-09-26T18:03:29.735Z